AMERIPRISE FINANCIAL INC (AMP)
AMERIPRISE FINANCIAL INC (AMP)
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total net revenues | NaN | 52 | NaN | NaN |
| Total benefits and expenses | NaN | 462 | NaN | NaN |
| Pretax loss before equity in earnings of subsidiaries | NaN | -410 | NaN | NaN |
| Effective tax rate | NaN | 205 | NaN | NaN |
| Loss before equity in earnings of subsidiaries | NaN | -615 | NaN | NaN |
| Equity in earnings of subsidiaries, net of tax | NaN | 4,178 | NaN | NaN |
| Net income | 915 | 1,008 | 912 | 1,060 |
| Depreciation, amortization and accretion, net | -9 | -20 | -19 | -27 |
| Deferred income tax expense (benefit) | -19 | -30 | 80 | 202 |
| Share-based compensation | 39 | 61 | 50 | 46 |
| Net realized investment (gains) losses | 0 | 2 | 11 | -15 |
| Net trading (gains) losses | 1 | 2 | 2 | 1 |
| Loss from equity method investments | -6 | -5 | 6 | 4 |
| Impairments and provision for loan and credit losses | -1 | 12 | 11 | 1 |
| Net (gains) losses of consolidated investment entities | -9 | -8 | 3 | 5 |
| Restricted and segregated investments | 0 | 0 | 0 | -319 |
| Deferred acquisition costs | -13 | -9 | -13 | -14 |
| Policyholder account balances, future policy benefits and claims, and market risk benefits, net | 728 | 829 | 1,603 | 1,238 |
| Derivatives, net of collateral | -1,040 | 453 | -572 | -545 |
| Receivables | 269 | -292 | 348 | -117 |
| Brokerage deposits | 14 | -170 | -69 | -121 |
| Accounts payable and accrued expenses | -467 | 288 | 246 | 179 |
| Current income tax, net | 240 | 168 | 137 | -593 |
| Other operating assets and liabilities of consolidated investment entities, net | 7 | -1 | 2 | -5 |
| Other, net | -308 | 241 | -184 | 136 |
| Net cash provided by (used in) operating activities | 459 | 2,669 | 2,204 | 1,764 |
| Proceeds from sales | 602 | 253 | 328 | 498 |
| Maturities, sinking fund payments and calls | 2,919 | 3,885 | 4,551 | 4,262 |
| Purchases | 4,070 | 5,206 | 3,656 | 3,808 |
| Proceeds from sales, maturities and repayments of mortgage loans | 111 | 87 | 67 | 49 |
| Funding of mortgage loans | 207 | 263 | 210 | 133 |
| Proceeds from sales, maturities and collections of other investments | 13 | 9 | 10 | 29 |
| Purchase of other investments | 3 | 4 | 6 | 15 |
| Purchase of investments by consolidated investment entities | 259 | 367 | 333 | 377 |
| Proceeds from sales, maturities and repayments of investments by consolidated investment entities | 245 | 325 | 237 | 259 |
| Purchase of land, buildings, equipment and software | 29 | 44 | 44 | 38 |
| Cash paid for written options with deferred premiums | 73 | 50 | 0 | 0 |
| Cash received from written options with deferred premiums | 18 | 15 | 0 | 5 |
| Cash paid for deposit receivables | 7 | 7 | 7 | 7 |
| Cash received for deposit receivables | 97 | 97 | 101 | 117 |
| Other, net | 26 | 323 | 34 | 39 |
| Net cash provided by (used in) investing activities | -669 | -1,593 | 1,004 | 802 |
| Proceeds from additions | 586 | 617 | 695 | 791 |
| Maturities, withdrawals and cash surrenders | 1,173 | 1,416 | 1,652 | 1,584 |
| Deposits and other additions | 266 | 326 | 377 | 336 |
| Net transfers from (to) separate accounts | -39 | 281 | -47 | -35 |
| Surrenders and other benefits | 327 | 377 | 359 | 356 |
| Change in banking deposits, net | 109 | 1,070 | 95 | -172 |
| Cash paid for purchased options with deferred premiums | 55 | 50 | 31 | 37 |
| Cash received for purchased options with deferred premiums | 110 | 50 | 46 | 0 |
| Issuance of long-term debt, net of issuance costs | 0 | 1 | 0 | 0 |
| Repayments of long-term debt | 0 | 2 | 2 | 503 |
| Dividends paid to shareholders | 148 | 149 | 151 | 152 |
| Repurchase of common shares | 874 | 895 | 701 | 581 |
| Borrowings of consolidated investment entities | 0 | 303 | 126 | 387 |
| Repayments of debt by consolidated investment entities | 1 | 304 | 256 | 34 |
| Other, net | NaN | 0 | 2 | NaN |
| Net cash provided by (used in) financing activities | -1,546 | -871 | -1,858 | -1,940 |
| Effect of exchange rate changes on cash | -9 | 1 | -8 | 25 |
| Net increase (decrease) in cash and cash equivalents, including amounts restricted | -1,765 | 206 | 1,342 | 651 |
| Cash and cash equivalents, including amounts restricted, at beginning of period | 11,158 | 9,489 | NaN | NaN |
| Cash and cash equivalents, including amounts restricted, at end of period | 9,393 | 11,158 | NaN | NaN |